Clinical Trials · NCT03279250

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Name: Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 2Gonadorelin

Phase: Phase 2
Recruitment status: Completed
Sponsor: M.D. Anderson Cancer Center
Enrollment: 86
Start date: Oct 2017
Locations: 1 site, United States
Primary endpoint: The Number of Participants With Rate of Pathologic Stage =< pT2N0 at Prostatectomy

View Gonadorelin compound reference